Austria
Tuberculosis profile
Population  2013 8.5 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.029 (0.029–0.03) 0.34 (0.34–0.35)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.93 (0.4–1.7) 11 (4.7–20)
Incidence  (includes HIV+TB) 0.71 (0.66–0.78) 8.4 (7.7–9.1)
Incidence (HIV+TB only) <0.01 (<0.01–0.014) 0.07 (0.07–0.16)
Case detection, all forms (%) 88 (80–95)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 2.5 (1–5.1) 38 (19–59)
MDR-TB cases among notified pulmonary
TB cases
12 (5–25) 14 (7–22)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 406   9
Pulmonary, clinically diagnosed 84   3
Extrapulmonary 121   1
       
Total new and relapse 624    
Previously treated, excluding relapses 25    
Total cases notified 649    
Among 624 new and relapse cases:
23 (4%) cases aged under 15 years; male:female ratio: 1.5
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 454 (112%) 26 (68%) 567
Laboratory-confirmed RR-/MDR-TB cases     16
Patients started on MDR-TB treatment     4
TB/HIV 2013 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 69
Previously treated cases, excluding relapse, registered in 2012 40
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011 64
XDR-TB cases started on second-line treatment in 2011 67
Laboratories 2013  
Is second-line drug susceptibility testing available?  
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-03-28 Data: www.who.int/tb/data